Text Size

Longitudinal Survey Analysis in Lymphoma Survivors (CLEAR Stress)

This study is currently recruiting participants.
Verified March 2012 by Weill Medical College of Cornell University
Sponsor:
Information provided by (Responsible Party):
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT01469754
First received: November 8, 2011
Last updated: March 7, 2012
Last verified: March 2012
History of Changes
  Purpose

Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD.

Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a "greater appreciation for life", a "stronger relationship with their family/friends," or a "new found level of spirituality" are examples of instances of posttraumatic growth.

Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.


Condition
Lymphoma
Posttraumatic Stress Disorder
Posttraumatic Growth
Coping
Resilience

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Coping With Lymphoma to Enhance Adjustment and Reduce Stress in Lymphoma Survivors

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Weill Medical College of Cornell University:

Estimated Enrollment: 200
Study Start Date: September 2011
Estimated Study Completion Date: September 2012
Groups/Cohorts
Lymphoma Survivors

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Lymphoma survivors who have completed initial treatment within the last 3 months

Criteria

Inclusion Criteria:

  • Diagnosis of Lymphoma (includes Waldenstrom's Macroglobulinemia)
  • Can read/write/understand English without a translator

Exclusion Criteria:

  • Currently Hospitalized
  • Active Psychosis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01469754

Contacts
Contact: Regina A Jacob, MD rej2008@med.cornell.edu

Locations
United States, New York
New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma Recruiting
New York, New York, United States, 10065
Principal Investigator: Regina A Jacob, MD            
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Regina A Jacob, MD WCMC Research Fellow
  More Information

Additional Information:
WCMC Link to Study Description  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT01469754     History of Changes
Other Study ID Numbers: 1107011786
Study First Received: November 8, 2011
Last Updated: March 7, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:
lymphoma
survivors
posttraumatic growth
posttraumatic stress
longitudinal

Additional relevant MeSH terms:
Lymphoma
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
 Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013